HTA Council Recommendation on Bivalent COVID-19 Vaccines as booster Date of OIC-SOH Approval: 25 April 2023 This assessment followed the HTA Council evaluation framework to evaluate COVID-19 vaccines using the following criteria: (1) responsiveness to magnitude and severity; (2) clinical efficacy and safety; (3) affordability, viability and feasibility; (4) household financial impact; (5) social impact; and continue reading : HTA Council Recommendation on Bivalent COVID-19 Vaccines as Booster
HTA Philippines Guidance: Efforts to Facilitate the HTA Transfer
The Department of Health (DOH) officially transferred the operations of the Health Technology Assessment (HTA) Philippines to the Department of Science and Technology (DOST) through a ceremonial turnover of the HTA Council and HTA Division from the DOH to the DOST on 06 March 2023 at the Philippine International Convention Center (PICC), Manila. To facilitate continue reading : HTA Philippines Guidance: Efforts to Facilitate the HTA Transfer
HTAC Guidance: PNF Inclusion of Recombinant Human Erythropoietin (Epoetin Alfa) 4000 IU/mL Solution for Injection (IV/SC) 1mL Pre-filled Syringe
(Updated as of 14 March 2023) On 24 January 2023, the OIC-Secretary of Health (SOH) approved the Health Technology Assessment Council (HTAC) recommendation for the government financing of recombinant Human Erythropoietin (epoetin alfa) 4000 IU/mL solution for injection (IV/SC), 1mL pre-filled syringe, for the management of chemotherapy-induced anemia in patients with non-myeloid disease through its minor inclusion continue reading : HTAC Guidance: PNF Inclusion of Recombinant Human Erythropoietin (Epoetin Alfa) 4000 IU/mL Solution for Injection (IV/SC) 1mL Pre-filled Syringe
HTAC Guidance: PNF Inclusion of Filgrastim 300 mcg/0.9 mL Solution (IV, SC), 0.9 mL Pre-filled Syringe
(Updated as of 14 March 2023) On 24 January 2023, the OIC-Secretary of Health (SOH) approved the Health Technology Assessment Council (HTAC) recommendation for the government financing of Filgrastim 300 mcg/0.9 mL solution (IV, SC), 0.9 mL pre-filled syringe, for the treatment of neutropenia in patients undergoing bone marrow transplantation and patients receiving myelosuppressive cancer chemotherapy through continue reading : HTAC Guidance: PNF Inclusion of Filgrastim 300 mcg/0.9 mL Solution (IV, SC), 0.9 mL Pre-filled Syringe
[Announcement] Ceremonial Turnover of HTA Implementation from the Department of Health to the Department of Science and Technology
The Department of Health (DOH) officially transferred the operations of the Health Technology Assessment (HTA) Philippines to the Department of Science and Technology (DOST) through a ceremonial turnover of the HTA Council and HTA Division from the DOH to the DOST on 06 March 2023 at the Philippine International Convention Center (PICC), Manila. DOH Officer-in-Charge-Secretary continue reading : [Announcement] Ceremonial Turnover of HTA Implementation from the Department of Health to the Department of Science and Technology